VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MMS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MMSMaximus, Inc.
$56.85$3.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

MMS logoMaximus, Inc.(MMS)Earnings, Financials & Key Ratios

MMS•NYSE
$56.85
10.3× P/E·Price updated Jul 7, 2026
SectorIndustrialsIndustryBusiness ServicesSub-IndustryGovernment Program and Health Outsourcing
AboutMaximus, Inc. provides business process services (BPS) to government health and human services programs. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers various BPS solutions, such as program administration, appeals and assessments, and related consulting works for U.S. state and local government programs, including the Affordable Care Act, Medicaid, the Children's Health Insurance Program, Temporary Assistance to Needy Families, child support programs, Preadmission Screening and Resident Reviews, and Independent Developmental Disability assessments. This segment also provides program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; person-centered independent disability, long-term sick, and other health assessments; and specialized consulting services. The U.S. Federal Services segment offers centralized citizen engagement centers and support services; document and record management; case management, citizen support, and consumer education; independent medical reviews and worker's compensation benefit appeals; Medicare and Medicaid appeals; and federal marketplace eligibility appeals. This segment also provides modernization of systems and information technology infrastructure; infrastructure operations and support services; software development, operations, and management services; and data analytics services. The Outside the U.S. segment offers BPS solutions for governments and commercial clients outside the United States, including health and disability assessments, program administration for employment services, and other job seeker-related services. The company was incorporated in 1975 and is headquartered in Tysons, Virginia.Show more
  • Revenue$5.43B+2.4%
  • EBITDA$723M+15.2%
  • Net Income$319M+3.9%
  • EPS (Diluted)5.51+10.4%
  • Gross Margin23.01%+5.3%
  • EBITDA Margin13.3%+12.6%
  • Operating Margin10.62%+14.6%
  • Net Margin5.87%+1.6%
  • ROE18.14%+3.8%

MMS Price & Volume

Maximus, Inc. (MMS) stock price & volume — 10-year historical chart

Loading chart...

Stagnating Revenue Growth Challenges Operational Margin Stability

Investment Thesis • Updated 2026Q2

VerdictNeutral
Growth:Decelerating
Profitability:Moderate
Financial:Healthy
Cash Flow:Mixed
Primary Risk:Contract re-compete and labor inflation

Key Thesis Takeaways

  • Maximus faces a challenging transition as the post-pandemic Medicaid redetermination tailwinds fade, resulting in a 4.1% year-over-year revenue contraction in 2026Q2.
  • While the company maintains a disciplined debt-to-equity ratio of 0.96, the reliance on labor-intensive service delivery models and significant goodwill of $1.8 billion creates persistent margin volatility.
  • Investors should monitor the company's ability to manage working capital swings and contract re-compete risks, as current earnings quality remains heavily influenced by non-operating items.

Verdict Logic

while the forward P/E of 6.46 suggests a discounted valuation, the inconsistent OCF/NI ratio, which swung to -2.60 in 2026Q1, warrants caution regarding the sustainability of cash-backed earnings.

MMS Growth Metrics

Maximus, Inc. (MMS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years9.97%
5 Years9.43%
3 Years5.46%
TTM-1.44%

Profit CAGR

10 Years7.3%
5 Years8.26%
3 Years16.11%
TTM24.42%

EPS CAGR

10 Years8.9%
5 Years10.2%
3 Years18.75%
TTM32.8%

Return on Capital

10 Years20.1%
5 Years13.69%
3 Years13.82%
Last Year17.4%

MMS Recent Earnings

Maximus, Inc. (MMS) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 7, 2026
Metric
Actual
Est
EPS
$2.07+4.5%
$1.98
Rev
$1.3B-0.6%
$1.3B
Q1 2026
Feb 5, 2026
Metric
Actual
Est
EPS
$1.85+0.5%
$1.84
Rev
$1.3B-2.2%
$1.4B
Q4 2025
Nov 20, 2025
Metric
Actual
Est
EPS
$1.62-3.0%
$1.67
Rev
$1.3B-1.7%
$1.3B
Q3 2025
Aug 7, 2025
Metric
Actual
Est
EPS
$2.16+55.4%
$1.39
Rev
$1.3B+0.5%
$1.3B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 7, 2026
$2.07vs $1.98+4.5%
$1.3Bvs $1.3B-0.6%
Q1 2026Feb 5, 2026
$1.85vs $1.84+0.5%
$1.3Bvs $1.4B-2.2%
Q4 2025Nov 20, 2025
$1.62vs $1.67-3.0%
$1.3Bvs $1.3B-1.7%
Q3 2025Aug 7, 2025
$2.16vs $1.39+55.4%
$1.3Bvs $1.3B+0.5%
Based on last 12 quarters of dataView full earnings history →

Latest MMS News

Recent stock market news and headlines for Maximus, Inc. (MMS)

Zacks Investment Research·20h ago
Why Maximus (MMS) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Business Wire·2 days ago
Maximus Declares Quarterly Cash Dividend of $0.33 per Share

TYSONS, Va.--(BUSINESS WIRE)--Maximus (NYSE: MMS), a leading provider of government services, announced today that its Board of Directors has approved a quarterly cash dividend of $0.33 per share, payable on August 31, 2026, to shareholders of record on August 14, 2026.

Peers Comparison

Key metrics vs top competitors for Maximus, Inc. (MMS)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
MMS logoMMSMaximus, Inc.Current
$56.85$2.99B10.322.36%5.87%18.14%2.09%
CACI logoCACICACI International Inc
$497.36$10.98B22.2812.64%5.86%13.15%—
SAIC logoSAICScience Applications International Corporation
$113.67$4.81B14.76-2.9%5.55%27.22%—
LDOS logoLDOSLeidos Holdings, Inc.
$108.57$13.66B9.753.07%7.77%27.1%—
BAH logoBAHBooz Allen Hamilton Holding Corporation
$63.31$7.58B9.16-6.37%7.57%81.03%—
CNXC logoCNXCConcentrix Corporation
$22.85$1.39B-1.122.15%-13.15%-41.8%—

Compare MMS vs Peers

Maximus, Inc. (MMS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CACI

Most directly comparable listed peer for MMS.

Scale Benchmark

vs LDOS

Larger-name benchmark to compare MMS against a more recognizable public peer.

Peer Set

Compare Top 5

vs CACI, SAIC, LDOS, BAH

MMS SEC Filings & Documents

Maximus, Inc. (MMS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 7, 2026·SEC

Material company update

Mar 11, 2026·SEC

Material company update

Feb 5, 2026·SEC

10-K Annual Reports

2
FY 2025

Nov 20, 2025·SEC

FY 2024

Nov 21, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 7, 2026·SEC

FY 2026

Feb 5, 2026·SEC

FY 2025

Aug 7, 2025·SEC

Get notified when MMS posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

MMS Frequently Asked Questions

Maximus, Inc. (MMS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Maximus, Inc.'s revenue?

Maximus, Inc. (MMS) reported $5.32B in revenue for fiscal year 2025. This represents a 5058% increase from $103.1M in 1996.

How fast is Maximus, Inc. growing?

Maximus, Inc. (MMS) grew revenue by 2.4% over the past year. Growth has been modest.

Is MMS profitable?

Yes, Maximus, Inc. (MMS) is profitable, generating $373.3M in net income for fiscal year 2025 (5.9% net margin).

Dividend & Returns
Does MMS pay dividends?

Yes, Maximus, Inc. (MMS) pays a dividend with a yield of 2.09%. This makes it attractive for income-focused investors.

What is MMS's return on equity?

Maximus, Inc. (MMS) has a return on equity (ROE) of 18.1%. This is reasonable for most industries.

What is Maximus, Inc.'s free cash flow?

Maximus, Inc. (MMS) generated $372.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in MMS back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →